Genetic analysis of chemoresistance in primary murine lymphomas

Clicks: 420
ID: 268639
2000
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #5 of 39 articles by views in Nature Medicine

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Understanding the basis of chemoresistance is a principal goal of molecular oncology. We have exploited a murine lymphoma model and retroviral gene transfer to rapidly generate a series of spontaneous tumors differing only in a gene of interest, and subsequently studied the impact of the test gene o …
Reference Key
ca2000naturegenetic Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Schmitt CA;Rosenthal CT;Lowe SW;;
Journal Nature Medicine
Year 2000
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/10973324
Keywords
experimental National Center for Biotechnology Information NCBI NLM MEDLINE Mice animals pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't Cultured Genes drug resistance adaptation biological transgenic neoplasms tumor cells clone cells gene transfer techniques lymphoma / genetics* pmid:10973324 doi:10.1038/79542 c a schmitt c t rosenthal s w lowe culture techniques / methods multiple / genetics* bcl-2* proto-oncogene proteins c-myc / biosynthesis proto-oncogene proteins c-myc / genetics retroviridae / genetics

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.